Sarcoma  >>  linsitinib (ASP7487)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
linsitinib (ASP7487) / Sling Therap
LINES, NCT02546544 / 2012-000616-28: Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma

Completed
2
16
Europe
Linsitinib, OSI-906, ASP7487
University of Oxford, European Organisation for Research and Treatment of Cancer - EORTC, European Commission, Astellas Pharma Inc, Oxford University Hospitals NHS Trust
Relapsed Ewing Sarcoma, Refractory Ewing Sarcoma
07/16
07/16

Download Options